Drug General Information
Drug ID
D0ZQ6N
Drug Name
CAR-T Cells targeting EGFRvIII
Drug Type
CAR T Cell Therapy
Indication Pancreatic cancer [ICD-11: 2C10] Phase 1 [1]
Company
First Affiliated Hospital of Harbin Medical University
Target and Pathway
Target(s) Epidermal growth factor receptor variant III (EGFR vIII) Target Info CAR-T-Cell-Therapy [1]
References
REF 1 ClinicalTrials.gov (NCT03267173) Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.